Clinical, functional and laboratory assessment of treatment efficacy in COPD patients

I. Baranova, I. Leshchenko (Yekaterinburg, Russian Federation)

Source: International Congress 2014 – Predictors
Session: Predictors
Session type: Thematic Poster Session
Number: 3619
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Baranova, I. Leshchenko (Yekaterinburg, Russian Federation). Clinical, functional and laboratory assessment of treatment efficacy in COPD patients. Eur Respir J 2014; 44: Suppl. 58, 3619

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014


Stable state MR-proadrenomedullin level in COPD patients; a validation study
Source: International Congress 2014 – Comorbidities
Year: 2014


Clinical and functional effectiveness of roflumilast in severe COPD patients
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013


Is clinical presentation different between men and women with COPD?
Source: International Congress 2014 – Clinical presentations
Year: 2014


Comparison of CAT and CCQ in a clinical COPD population
Source: International Congress 2014 – Clinical presentations
Year: 2014

Mortality predictors in stable COPD
Source: International Congress 2014 – Predictors
Year: 2014


The role of COPD in development of osteoporosis
Source: International Congress 2014 – Markers
Year: 2014


COPD and depression: Prevalence and interaction
Source: International Congress 2014 – Comorbidities
Year: 2014


Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability
Source: International Congress 2014 – Markers
Year: 2014

Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016

Integrated care reduces hospital utilization among patients with severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Assessment of the COPD patients’ care: An audit of clinical practice
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013


Distribution and outcomes of the new Spanish phenotype-based guideline for COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Metabolic syndrome in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014

Effects of pharmacist interventions to inhalation medication adherence and lung functions in COPD patients at one stop service clinic
Source: International Congress 2014 – COPD exacerbations
Year: 2014



COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


COPD assessment for symptoms and functional condition in pulmonary rehabilitation
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015

Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes
Source: International Congress 2014 – Markers
Year: 2014


Efficacy of early COPD diagnosis and intervention system
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


What should be part of a comprehensive assessment of COPD?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016